Editorial: “Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma”

Wei Cao,Qiang Shen,Ming Yann Lim

DOI: https://doi.org/10.3389/fonc.2021.785001

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:EDITORIAL article Front. Oncol., 23 December 2021Sec. Head and Neck Cancer Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.785001

What problem does this paper attempt to address?

Advances in Nonsurgical Treatment of Head and Neck Squamous Cell Carcinoma

Zang Shoumei,Yan Danfang,Yan Senxiang

DOI: https://doi.org/10.3760/cma.j.issn.1673-422x.2019.12.007

2019-01-01

Abstract:Locally advanced head and neck squamous cell carcinoma requires a multidisciplinary approach, including surgery followed by radiotherapy, with or without chemotherapy, or definitive concurrent chemoradiotherapy. The application of induction chemotherapy remains controversial. Cetuximab has achieved satisfactory results in the treatment of head and neck squamous cell carcinoma. Immunocheckpoint inhibitors against the receptor programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) have demonstrated clinical efficacy in head and neck squamous carcinoma. However, only a small subset of patients can benefit from anti-PD-1 and anti-PD-L1 monotherapy. To improve the effectiveness of immunotherapy, combined of immunotherapy and other treatments has become an alternative strategy. Key words: Head and neck neoplasms; Radiotherapy; Cetuximab; Immunotherapy; Chemotherapy
Functional Analysis of Long-Chain Non-Coding RNA in Oral Squamous Cell Carcinoma

Qing-Yun Duan,Xiong Zhang,Meng Wu,Fu Yu,Mei Xu,Wei-Jie Dong,Min Gan,Min-Song Tu,Hong-Bing Jian

DOI: https://doi.org/10.21037/tcr.2019.12.67

2020-01-01

Translational Cancer Research

Abstract:Background: This study aimed to investigate the expression profile of long-chain non-coding RNA (lncRNA) in oral squamous cell carcinoma (OSCC) and to explore the biological functions of differentially expressed lncRNA in the cancer tissues as compared with adjacent normal tissues, and the differentially expressed lncRNAs related to OSCC were screened. Methods: High-throughput lncRNA microarray assay was used to detect the expression of lncRNA and mRNA in the OSCC tissues and adjacent normal tissues from five patients. The expression profiles of the lncRNA and mRNA in the cancer tissues and adjacent normal tissues were analyzed and the differentially expressed lncRNA and mRNAs were identified. The differentially expressed mRNA was analyzed with GO, Pathway and disease annotation enrichment database, and the mRNAs related to the tumor and the lncRNA-mRNA co-expression network were employed to screen the key lncRNA related to the occurrence and development of OSCC. Results: A total of 3,022 differentially expressed lncRNAs and 4,364 differentially expressed mRNAs were identified in the OSCC tissues as compared with adjacent normal tissues. A further analysis revealed 130 major differentially expressed mRNAs related to the tumor. When the correlation was >0.99 or <-0.99 and P value was <0.05, there were 73 differentially expressed mRNA in case of mRNA/lncRNA co-expression. The intersection of two gene symbols resulted in the nine lncRNAs closely related to the OSCC, in which five showed up-regulation and six had down-regulation. Based on the co-expression of the lncRNAs and mRNAs (correlation 40.99 or correlation -0.99 and P value <0.05), there were differentially expressed mRNAs with co-expression with lncRNA. Conclusions: The differentially expressed lncRNAs identified in this study are related to the occurrence and development of OSCC. This may provide new therapeutic targets and biomarkers for OSCC and is also helpful for further investigation of pathogenesis of OSCC.
Transcriptomic Model-Based Lncrnas and Mrnas Serve As Independent Prognostic Indicators in Head and Neck Squamous Cell Carcinoma

Zhi-Li Zhang,Li-Jing Zhao,Lin Xu,Liang Chai,Feng Wang,Ya-Ping Xu,Shui-Hong Zhou,Yong Fu

DOI: https://doi.org/10.3892/ol.2019.10213

2019-01-01

Oncology Letters

Abstract:Head and neck squamous cell carcinoma (HNSC) is one of most common types of cancer worldwide, and mRNAs and long non-coding RNAs (lncRNAs) have been identified as prognostic biomarkers in HNSC. In the present study, using gene expression datasets from multiple platforms, survival-associated genes in HNSC were identified. Subsequently, a combination of 17 genes (14 mRNAs and 3 lncRNA) was optimized using random forest variable hunting and a risk score model for HNSC prognosis was developed using a cohort from The Cancer Genome Atlas. Patients with high-risk scores tend to have earlier disease recurrence and lower survival rates, compared with those with low-risk scores. This observation was further validated in three independent datasets (GSE41613, GSE10300 and E-MTAB-302). Association analysis revealed that the risk score is independent of other clinicopathological observations. On the basis of the results depicted in the nomogram, the risk score performs better in 3-year survival rate prediction than other clinical observations. In summary, the lncRNA-mRNA signature-based risk score successfully predicts the survival of HNSC and serves as an indicator of prognosis.
Long Non-Coding RNAs As Novel Biomarkers and Therapeutic Targets in Head and Neck Cancers.

Yang Qiu,Yanfei Deng

2014-01-01

Abstract:Long non-coding RNAs (lncRNAs) are generally defined as RNA molecules greater than 200 nt in length and without protein-coding property that different from housekeeping RNAs such as tRNAs, rRNAs, and snRNAs, and independent from small RNAs with specific molecular processing machinery such as micro- or piwi-RNAs. LncRNAs are a novel class of mRNA-like transcripts which contribute to cancer development and progression and accelerate cancer cells proliferation, invasion, metastasis, and apoptosis. These research results indicate the potential of lncRNAs as prospective novel biomarkers for diagnosis, therapeutic targets and prognosis for cancers. In this review, we synthesize present study results to highlight aberration of lncRNAs in various types of head and neck cancers, and try to clarify the molecular mechanisms of lncRNAs affecting the oncogenesis and progression of head and neck cancer, as well as pay particular attention to provide a new avenue to the diagnosis and treatment strategy.
Editorial: Non-coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights into the Mechanisms of Cancer Therapeutic Resistance, Volume II

Peixin Dong,Lei Chang,Junming Yue

DOI: https://doi.org/10.3389/fcell.2023.1161164

IF: 5.5

2023-01-01

Frontiers in Cell and Developmental Biology

Abstract:EDITORIAL article Front. Cell Dev. Biol., 14 February 2023Sec. Epigenomics and Epigenetics Volume 11 - 2023 | https://doi.org/10.3389/fcell.2023.1161164
Long non-coding RNAs in head and neck squamous cell carcinoma: Diagnostic biomarkers, targeted therapies, and prognostic roles

Xiang Meng,Zi-Fei Wang,Qiu-Yue Lou,Abigail N. Rankine,Wan-Xin Zheng,Zi-Hao Zhang,Lei Zhang,Hao Gu

DOI: https://doi.org/10.1016/j.ejphar.2021.174114

IF: 5.195

2021-07-01

European Journal of Pharmacology

Abstract:At present, emerging evidence shows that non-coding RNAs (ncRNAs) play crucial roles for development of multiple tumors. Amongst these ncRNAs, long non-coding RNAs (lncRNAs) play prominent roles in physiological and pathological processes. LncRNAs are RNA transcripts larger than 200 nucleotides and have been shown to serve important regulatory roles in different types of cancer via interactions with DNA, RNA and proteins. Head and neck squamous cell carcinoma (HNSCC) is one of the most malignant tumors with low survival rates in advanced stages. Recently, lncRNAs have been demonstrated to be involved in a wide range of biological processes, including proliferation, metastasis, and prognosis of HNSCC. Therefore, this review describes molecular mechanisms of up- or down-regulation of lncRNAs and expounds their functions in pathology and clinical practices in HNSCC. It also highlights their potential clinical applications as biomarkers for the diagnosis, prognosis, and treatment of HNSCC. However, studies on lncRNAs are still not comprehensive, and more investigations are needed in the future.

pharmacology & pharmacy
The Role of Long Non-Coding RNAs in the Pathogenesis of Head and Neck Squamous Cell Carcinoma

Man Jiang,Fang Liu,An‐Gang Yang,Wei Wang,Rui Zhang

DOI: https://doi.org/10.1016/j.omto.2021.12.001

2022-01-01

Abstract:Head and neck cancers are a heterogeneous collection of malignancies of the upper aerodigestive tract, salivary glands, and thyroid. However, the molecular mechanisms underlying the carcinogenesis of head and neck squamous cell carcinomas (HNSCCs) remain poorly understood. Over the past decades, overwhelming evidence has demonstrated the regulatory roles of long non-coding RNAs (lncRNAs) in tumorigenesis, including HNSCC. Notably, these lncRNAs have vital roles in gene regulation and affect various aspects of cellular homeostasis, including proliferation, survival, and metastasis. They exert regulating functions by interacting with nucleic acids or proteins and affecting cancer cell signaling. LncRNAs represent a burgeoning field of cancer research, and we are only beginning to understand the importance and complicity of lncRNAs in HNSCC. In this review, we summarize the deregulation and function of lncRNAs in human HNSCC. We also review the working mechanism of lncRNAs in HNSCC pathogenesis and discuss the potential application of lncRNAs as diagnostic/prognostic tools and therapeutic targets in human HNSCC.
Editorial: Combating cancer with natural products: Non-coding RNA and RNA modification.

Yongye Huang,Yue Hou,Peng Qu,Yun Dai

DOI: https://doi.org/10.3389/fphar.2023.1149777

IF: 5.6

2023-01-01

Frontiers in Pharmacology

Abstract:EDITORIAL article Front. Pharmacol., 10 February 2023Sec. Pharmacology of Anti-Cancer Drugs Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1149777
The non-coding landscape of head and neck squamous cell carcinoma

Angela E. Zou,Hao Zheng,Maarouf A. Saad,Mehran Rahimy,Jonjei Ku,Selena Z. Kuo,Thomas K. Honda,Jessica Wang-Rodriguez,Yinan Xuan,Avinaash Korrapati,Vicky Yu,Pranav Singh,Jennifer R. Grandis,Charles C. King,Scott M. Lippman,Xiao Qi Wang,Andrew Hinton,Weg M. Ongkeko

DOI: https://doi.org/10.18632/oncotarget.9979

2016-06-13

Oncotarget

Abstract:Head and neck squamous cell carcinoma (HNSCC) is an aggressive disease marked by frequent recurrence and metastasis and stagnant survival rates. To enhance molecular knowledge of HNSCC and define a non-coding RNA (ncRNA) landscape of the disease, we profiled the transcriptome-wide dysregulation of long non-coding RNA (lncRNA), microRNA (miRNA), and PIWI-interacting RNA (piRNA) using RNA-sequencing data from 422 HNSCC patients in The Cancer Genome Atlas (TCGA). 307 non-coding transcripts differentially expressed in HNSCC were significantly correlated with patient survival, and associated with mutations in TP53, CDKN2A, CASP8, PRDM9, and FBXW7 and copy number variations in chromosomes 3, 5, 7, and 18. We also observed widespread ncRNA correlation to concurrent TP53 and chromosome 3p loss, a compelling predictor of poor prognosis in HNSCCs. Three selected ncRNAs were additionally associated with tumor stage, HPV status, and other clinical characteristics, and modulation of their expression in vitro reveals differential regulation of genes involved in epithelial-mesenchymal transition and apoptotic response. This comprehensive characterization of the HNSCC non-coding transcriptome introduces new layers of understanding for the disease, and nominates a novel panel of transcripts with potential utility as prognostic markers or therapeutic targets.
Editorial: Insights into non-coding RNAs in programmed cell death, from molecular mechanism of tumorigenesis to therapeutic targets.

Jinhui Liu,Peixin Dong

DOI: https://doi.org/10.3389/fonc.2023.1239782

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:EDITORIAL article Front. Oncol., 27 June 2023Sec. Molecular and Cellular Oncology Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1239782
Long Intergenic Non-Coding RNAs in HNSCC: From “Junk DNA” to Important Prognostic Factor

Joanna Kozłowska,Tomasz Kolenda,Paulina Poter,Joanna Sobocińska,Kacper Guglas,Maciej Stasiak,Renata Bliźniak,Anna Teresiak,Katarzyna Lamperska

DOI: https://doi.org/10.3390/cancers13122949

2021-06-12

Cancers

Abstract:Head and neck squamous cell carcinoma is one of the most common and fatal cancers worldwide. Even a multimodal approach consisting of standard chemo- and radiotherapy along with surgical resection is only effective in approximately 50% of the cases. The rest of the patients develop a relapse of the disease and acquire resistance to treatment. Especially this group of individuals needs novel, personalized, targeted therapy. The first step to discovering such solutions is to investigate the tumor microenvironment, thus understanding the role and mechanism of the function of coding and non-coding sequences of the human genome. In recent years, RNA molecules gained great interest when the complex character of their impact on our biology allowed them to come out of the shadows of the “junk DNA” label. Furthermore, long non-coding RNAs (lncRNA), specifically the intergenic subgroup (lincRNA), are one of the most aberrantly expressed in several malignancies, which makes them particularly promising future diagnostic biomarkers and therapeutic targets. This review contains characteristics of known and validated lincRNAs in HNSCC, such as XIST, MALAT, HOTAIR, HOTTIP, lincRNA-p21, LINC02487, LINC02195, LINC00668, LINC00519, LINC00511, LINC00460, LINC00312, and LINC00052, with a description of their prognostic abilities. Even though much work remains to be done, lincRNAs are important factors in cancer biology that will become valuable biomarkers of tumor stage, outcome prognosis, and contribution to personalized medicine.

oncology
Long noncoding RNAs in head and neck cancer.

Xiuhua Li,Yongbing Cao,Xiaojian Gong,Hongjiao Li

DOI: https://doi.org/10.18632/oncotarget.12960

2017-01-01

Oncotarget

Abstract:Head and neck cancers (HNCs) include a series of malignant tumors arising in epithelial tissues, typically oral cancer, laryngeal cancer, nasopharynx cancer and thyroid cancer. HNCs are important contributors to cancer incidence and mortality, leading to approximately 225,100 new patients and 77,500 deaths in China every year. Determination of the mechanisms of HNC carcinogenesis and progression is an urgent priority in HNC treatment. Long noncoding RNAs (lncRNAs) are noncoding RNAs longer than 200 bps. lncRNAs have been reported to participate in a broad scope of biological processes, and lncRNA dysregulation leads to diverse human diseases, including cancer. In this review, we focus on lncRNAs that are dysregulated in HNCs, summarize the latest findings regarding the function and molecular mechanisms of lncRNAs in HNC carcinogenesis and progression, and discuss the clinical application of lncRNAs in HNC diagnosis, prognosis and therapy.
Small Nucleolar RNAs in Head and Neck Squamous Cell Carcinomas

C. Duan,Y. Abola,J. Zhao,Y. Wang

DOI: https://doi.org/10.1177/00220345241279369

2024-10-26

Journal of Dental Research

Abstract:Journal of Dental Research, Ahead of Print. Small nucleolar RNAs (snoRNAs), a distinct class of noncoding RNAs, encompass highly diverse structures and have a range of 60 to 300 nucleotides in length. About 90% of human snoRNAs are intronic and embedded within introns of their host gene transcripts. Most snoRNAs enriched in specific tissue correlate in abundance with their parental host genes. Advancements in high-throughput sequencing have facilitated the discovery of dysregulated snoRNA expression in numerous human malignancies including head and neck squamous cell carcinoma (HNSCC). Hundreds of differentially expressed snoRNAs have been identified in HNSCC tissues. Among 1,524 snoRNA genes in a 567 HNSCC cohort, 113 snoRNAs were found to be survival related. As for snoRNA's roles in HNSCC, based on the available evidence, dysregulated snoRNAs are closely associated with the carcinogenesis and development of HNSCC. Upregulated snoRNAs have been shown to augment the expression of other oncogenes or activate the Wnt/β-catenin signaling pathway, thereby promoting tumor cell viability, glycolysis, migration, and the epithelial-mesenchymal transition while inhibiting apoptosis in vitro. In vivo animal studies have further elucidated the functional roles of snoRNAs. Knockdown of host genes of these snoRNAs suppressed the Wnt/β-catenin signaling pathway and restrained tumor proliferation and aggressiveness in mice. The putative mechanisms underlying these observations are associated with the biological functions of snoRNAs, primarily involving microRNA-like functions through the generation of microRNA-like fragments and regulation of alternative splicing to yield diverse transcripts. While most of the snoRNAs are upregulated in HNSCC, 4 downregulated snoRNAs have been identified and annotated. SNORA36B (implicated in the regulation of DNA templates) and U3 (chr17, influencing cell proliferation) may serve as protective factors associated with prolonged overall survival. This review describes the viable structures of snoRNAs, endeavors to refine snoRNA sequencing technology, and summarizes snoRNAs' expression profile as well as their role in HNSCC progression for potential diagnostic and therapeutic strategies for HNSCC management.

dentistry, oral surgery & medicine
Novel insights on oral squamous cell carcinoma management using long non-coding RNAs

Subhayan Sur,Dimple Davray,Soumya Basu,Supriya Kheur,Jayanta Kumar Pal,Shuchi Nagar,Avinash Sanap,Bhimappa M Rudagi,Samir Gupta

DOI: https://doi.org/10.32604/or.2024.052120

2024-09-18

Abstract:Oral squamous cell carcinoma (OSCC) is one of the most prevalent forms of head and neck squamous cell carcinomas (HNSCC) with a poor overall survival rate (about 50%), particularly in cases of metastasis. RNA-based cancer biomarkers are a relatively advanced concept, and non-coding RNAs currently have shown promising roles in the detection and treatment of various malignancies. This review underlines the function of long non-coding RNAs (lncRNAs) in the OSCC and its subsequent clinical implications. LncRNAs, a class of non-coding RNAs, are larger than 200 nucleotides and resemble mRNA in numerous ways. However, unlike mRNA, lncRNA regulates multiple druggable and non-druggable signaling molecules through simultaneous interaction with DNA, RNA, proteins, or microRNAs depending on concentration and localization in cells. Upregulation of oncogenic lncRNAs and down-regulation of tumor suppressor lncRNAs are evident in OSCC tissues and body fluids such as blood and saliva indicating their potential as valuable biomarkers. Targeted inhibition of candidate oncogenic lncRNAs or over-expression of tumor suppressor lncRNAs showed potential therapeutic roles in in-vivo animal models. The types of lncRNAs that are expressed differentially in OSCC tissue and bodily fluids have been systematically documented with specificity and sensitivity. This review thoroughly discusses the biological functions of such lncRNAs in OSCC cell survival, proliferation, invasion, migration, metastasis, angiogenesis, metabolism, epigenetic modification, tumor immune microenvironment, and drug resistance. Subsequently, we addressed the diagnostic and therapeutic importance of lncRNAs in OSCC pre-clinical and clinical systems, providing details on ongoing research and outlining potential future directions for advancements in this field. In essence, this review could be a valuable resource by offering comprehensive and current insights into lncRNAs in OSCC for researchers in fundamental and clinical domains.
Long Non-Coding RNAs in Oral Squamous Cell Carcinoma: Biologic Function, Mechanisms and Clinical Implications

Lei Zhang,Xiang Meng,Xinwei Zhu,Dengcheng Yang,Ran Chen,Yong Jiang,Tao Xu

DOI: https://doi.org/10.1186/s12943-019-1021-3

IF: 37.3

2019-01-01

Molecular Cancer

Abstract:There is growing evidence that regions of the genome that cannot encode proteins play an important role in diseases. These regions are usually transcribed into long non-coding RNAs (lncRNAs). LncRNAs, little or no coding potential, are defined as capped transcripts longer than 200 nucleotides. New sequencing technologies have shown that a large number of aberrantly expressed lncRNAs are associated with multiple cancer types and indicated they have emerged as an important class of pervasive genes during the development and progression of cancer. However, the underlying mechanism in cancer is still unknown. Therefore, it is necessary to elucidate the lncRNA function. Notably, many lncRNAs dysregulation are associated with Oral squamous cell carcinoma (OSCC) and affect various aspects of cellular homeostasis, including proliferation, survival, migration or genomic stability. This review expounds the up- or down-regulation of lncRNAs in OSCC and the molecular mechanisms by which lncRNAs perform their function in the malignant cell. Finally, the potential of lncRNAs as non-invasive biomarkers for OSCC diagnosis are also described. LncRNAs hold promise as prospective novel therapeutic targets, but more research is needed to gain a better understanding of their biologic function.
How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis

Guomiao Zhao,Yaru Fu,Zhifang Su,Rongling wu

DOI: https://doi.org/10.1159/000494009

2018-01-01

Cellular Physiology and Biochemistry

Abstract:Background/Aims: Long non-coding RNAs (lncRNAs) act as competing endogenous RNAs (ceRNAs) to compete for microRNAs (miRNAs) in cancer metastasis. Head and neck squamous cell carcinoma (HNSCC) is one of the most common human cancers and rare biomarkers could predict the clinical prognosis of this disease and its therapeutic effect. Methods: Weighted gene co-expression network analysis (WGCNA) was performed to identify differentially expressed mRNAs (DEmRNAs) that might be key genes. GO enrichment and protein–protein interaction (PPI) analyses were performed to identify the principal functions of the DEmRNAs. An lncRNA-miRNA-mRNA network was constructed to understand the regulatory mechanisms in HNSCC. The prognostic signatures of mRNAs, miRNAs, and lncRNAs were determined by Gene Expression Profiling Interactive Analysis (GEPIA) and using Kaplan–Meier survival curves for patients with lung squamous cell carcinoma. Results: We identified 2,023 DEmRNAs, 1,048 differentially expressed lncRNAs (DElncRNAs), and 82 differentially expressed miRNAs (DEmiRNAs). We found that eight DEmRNAs, 53 DElncRNAs, and 16 DEmiRNAs interacted in the ceRNA network. Three ceRNAs (HCG22, LINC00460 and STC2) were significantly correlated with survival. STC2 transcript levels were significantly higher in tumour tissues than in normal tissues, and the STC2 expression was slightly upregulated at different stages of HNSCC. Conclusion: LINC00460, HCG22 and STC2 exhibited aberrant levels of expression and may participate in the pathogenesis of HNSCC.
Editorial: Insights into Non-Coding RNAs in Programmed Cell Death, from Molecular Mechanism of Tumorigenesis to Therapeutic Targets

Jinhui Liu,Peixin Dong

DOI: https://doi.org/10.3389/fonc.2023.1239782

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:COPYRIGHT © 2023 Liu and Dong. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Editorial PUBLISHED 27 June 2023 DOI 10.3389/fonc.2023.1239782
Non-coding ribonucleic acid and head and neck cancer

HUANG Feng-hao,LI Jiang

DOI: https://doi.org/10.3969/j.issn.1673-5749.2008.05.026

2008-01-01

Abstract:Non-coding ribonucleic acid(ncRNA) is a kind of important functional biological molecule.Now,the property and role of regulation of few kind of ncRNA has been known in academic circles,but not more other kinds.This article briefly introduces the classification,biological significance and functions of ncRNA,and reviews the role of ncRNA in tumorigenesis,diagnosis and therapy of head and neck cancers.
Non-coding RNA and drug resistance in head and neck cancer

Yulong Zhang,Yingming Peng,Bingqin Lin,Shuai Yang,Feiqiang Deng,Xuan Yang,An Li,Wanyi Xia,Chenxi Gao,Shaona Lei,Wei Liao,Qi Zeng

DOI: https://doi.org/10.20517/cdr.2024.59

2024-09-20

Cancer Drug Resist

Abstract:Head and neck cancer (HNC) is ranked as the sixth most common malignant tumor, and the overall survival rate with current treatment options remains concerning, primarily due to drug resistance that develops following antitumor therapy. Recent studies indicate that non-coding RNAs play a crucial role in drug resistance among HNC patients. This article systematically reviews the current research landscape, explores novel targets and treatment strategies related to non-coding RNAs and HNC resistance, raises some unresolved issues, and discusses five promising research directions in this field: ferroptosis, nanomedicine, exosomes, proteolysis-targeting chimeras (PROTACs), and artificial intelligence. We hope that our work will contribute to advancing research on overcoming HNC resistance through the regulation of non-coding RNAs.
The Two Faces of Immune-Related lncRNAs in Head and Neck Squamous Cell Carcinoma

Lesly J. Bueno-Urquiza,Marcela G. Martínez-Barajas,Carlos E. Villegas-Mercado,Jonathan R. García-Bernal,Ana L. Pereira-Suárez,Maribel Aguilar-Medina,Mercedes Bermúdez

DOI: https://doi.org/10.3390/cells12050727

IF: 6

2023-02-25

Cells

Abstract:Head and neck squamous cell carcinoma (HNSCC) is a group of cancers originating from the mucosal epithelium in the oral cavity, larynx, oropharynx, nasopharynx, and hypopharynx. Molecular factors can be key in the diagnosis, prognosis, and treatment of HNSCC patients. Long non-coding RNAs (lncRNAs) are molecular regulators composed of 200 to 100,000 nucleotides that act on the modulation of genes that activate signaling pathways associated with oncogenic processes such as proliferation, migration, invasion, and metastasis in tumor cells. However, up until now, few studies have discussed the participation of lncRNAs in modeling the tumor microenvironment (TME) to generate a protumor or antitumor environment. Nevertheless, some immune-related lncRNAs have clinical relevance, since AL139158.2, AL031985.3, AC104794.2, AC099343.3, AL357519.1, SBDSP1, AS1AC108010.1, and TM4SF19-AS1 have been associated with overall survival (OS). MANCR is also related to poor OS and disease-specific survival. MiR31HG, TM4SF19-AS1, and LINC01123 are associated with poor prognosis. Meanwhile, LINC02195 and TRG-AS1 overexpression is associated with favorable prognosis. Moreover, ANRIL lncRNA induces resistance to cisplatin by inhibiting apoptosis. A superior understanding of the molecular mechanisms of lncRNAs that modify the characteristics of TME could contribute to increasing the efficacy of immunotherapy.

cell biology

Editorial: “Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma”

Advances in Nonsurgical Treatment of Head and Neck Squamous Cell Carcinoma

Functional Analysis of Long-Chain Non-Coding RNA in Oral Squamous Cell Carcinoma

Transcriptomic Model-Based Lncrnas and Mrnas Serve As Independent Prognostic Indicators in Head and Neck Squamous Cell Carcinoma

Long Non-Coding RNAs As Novel Biomarkers and Therapeutic Targets in Head and Neck Cancers.

Editorial: Non-coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights into the Mechanisms of Cancer Therapeutic Resistance, Volume II

Long non-coding RNAs in head and neck squamous cell carcinoma: Diagnostic biomarkers, targeted therapies, and prognostic roles

The Role of Long Non-Coding RNAs in the Pathogenesis of Head and Neck Squamous Cell Carcinoma

Editorial: Combating cancer with natural products: Non-coding RNA and RNA modification.

The non-coding landscape of head and neck squamous cell carcinoma

Editorial: Insights into non-coding RNAs in programmed cell death, from molecular mechanism of tumorigenesis to therapeutic targets.

Long Intergenic Non-Coding RNAs in HNSCC: From “Junk DNA” to Important Prognostic Factor

Long noncoding RNAs in head and neck cancer.

Small Nucleolar RNAs in Head and Neck Squamous Cell Carcinomas

Novel insights on oral squamous cell carcinoma management using long non-coding RNAs

Long Non-Coding RNAs in Oral Squamous Cell Carcinoma: Biologic Function, Mechanisms and Clinical Implications

How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis

Editorial: Insights into Non-Coding RNAs in Programmed Cell Death, from Molecular Mechanism of Tumorigenesis to Therapeutic Targets

Non-coding ribonucleic acid and head and neck cancer

Non-coding RNA and drug resistance in head and neck cancer

The Two Faces of Immune-Related lncRNAs in Head and Neck Squamous Cell Carcinoma